Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Genetics

Genomic medicine service to be rolled out in NHS hospitals from October 2018

The 100,000 Genomes Project has sequenced over 70,000 genomes and is on track to reach its goal of 100,000 genomes by the end of 2018.

A NHS Genomic Medicine Service will be rolled out across England from October 2018 to help embed genome sequencing into routine hospital care and ensure that the NHS “stays at the forefront of healthcare delivery”, it has been announced.

The development comes as the 100,000 Genomes Project has sequenced over 70,000 genomes, with Genomics England adding that the project is on track to reach its goal of 100,000 genomes by the end of 2018.

NHS England says that the NHS Genomic Medicine Service will provide “comprehensive and equitable access to the latest in genomic testing” and will enable more personalised treatments.

Lord James O’Shaughnessy, under secretary of state for health in the House of Lords, said: “Genomic medicine is no longer a thing of the future, it’s here now and helping to save lives.”

John Mattick, chief executive of Genomic England, said: “As the technology and our understanding continue to grow over the coming years, we will provide genome analyses to inform personalised treatments and preventative actions tailored to individual circumstances.”

After the 100,000 genome project is completed, Genomics England will continue to support the NHS Genomic Medicine Service and encourage new discoveries and their translation into novel medicines and treatments.

Mark Caulfield, chief scientist at Genomics England, said: “It has already changed the lives of many patients with cancer or a rare disease in the UK, and now this programme will expand to further transform genomic health in the NHS with improved outcomes for many more.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205107

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Genomic sequencing

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.